UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Overexpression of miR-199b-5p in Colony Forming Unit-Hill’s Colonies Positively Mediates the Inflammatory Response in Subclinical Cardiovascular Disease Model: Metformin Therapy Attenuates Its Expression

International journal of molecular sciences, 2024-08, Vol.25 (15), p.8087

2024

Volltextzugriff (PDF)

MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus)

Journal of translational medicine, 2021-04, Vol.19 (1), p.140-140, Article 140

2021

Volltextzugriff (PDF)

The Influence of Age on the Relationship between Subclinical Hypothyroidism and Ischemic Heart Disease: A Metaanalysis

The journal of clinical endocrinology and metabolism, 2008-08, Vol.93 (8), p.2998-3007

2008

Volltextzugriff (PDF)

Decoding of miR-7-5p in Colony Forming Unit-Hill Colonies as a Biomarker of Subclinical Cardiovascular Disease-A MERIT Study

International journal of molecular sciences, 2023-07, Vol.24 (15), p.11977

2023

Volltextzugriff (PDF)

The Role of miR-342 in Vascular Health. Study in Subclinical Cardiovascular Disease in Mononuclear Cells, Plasma, Inflammatory Cytokines and PANX2

International journal of molecular sciences, 2020-10, Vol.21 (19), p.7217

2020

Volltextzugriff (PDF)

Proangiogenic Effect of Metformin in Endothelial Cells Is via Upregulation of VEGFR1/2 and Their Signaling under Hyperglycemia-Hypoxia

International journal of molecular sciences, 2018-01, Vol.19 (1), p.293

2018

Volltextzugriff (PDF)

Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1/2 and other parameters of vascular health

Stem cell research & therapy, 2021-05, Vol.12 (1), p.249-249, Article 249

2021

Volltextzugriff (PDF)

Subclinical Thyrotoxicosis and Cardiovascular Risk: Assessment of Circulating Endothelial Progenitor Cells, Proangiogenic Cells, and Endothelial Function

Frontiers in endocrinology (Lausanne), 2022-07, Vol.13, p.894093-894093

2022

Volltextzugriff (PDF)

Deciphering the Role of miR-200c-3p in Type 1 Diabetes (Subclinical Cardiovascular Disease) and Its Correlation with Inflammation and Vascular Health

International journal of molecular sciences, 2022-12, Vol.23 (24), p.15659

2022

Volltextzugriff (PDF)

Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study

International journal of molecular sciences, 2018-10, Vol.19 (10), p.3242

2018

Volltextzugriff (PDF)

Upregulation of Anti-Angiogenic miR-106b-3p Correlates Negatively with IGF-1 and Vascular Health Parameters in a Model of Subclinical Cardiovascular Disease: Study with Metformin Therapy

Biomedicines, 2024-01, Vol.12 (1), p.171

2024

Volltextzugriff (PDF)

Upregulated miR-18a-5p in Colony Forming Unit-Hill’s in Subclinical Cardiovascular Disease and Metformin Therapy; MERIT Study

Biomedicines, 2022-08, Vol.10 (9), p.2136

2022

Volltextzugriff (PDF)

Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up

Frontiers in endocrinology (Lausanne), 2022-03, Vol.13, p.843857-843857

2022

Volltextzugriff (PDF)

Levothyroxine Improves Abnormal Cardiac Bioenergetics in Subclinical Hypothyroidism: A Cardiac Magnetic Resonance Spectroscopic Study

The journal of clinical endocrinology and metabolism, 2015-04, Vol.100 (4), p.E607-E610

2015

Volltextzugriff (PDF)

The Beneficial Effect of l-Thyroxine on Cardiovascular Risk Factors, Endothelial Function, and Quality of Life in Subclinical Hypothyroidism: Randomized, Crossover Trial

The journal of clinical endocrinology and metabolism, 2007-05, Vol.92 (5), p.1715-1723

2007

Volltextzugriff (PDF)

Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus

PloS one, 2015-06, Vol.10 (6), p.e0123550-e0123550

2015

Volltextzugriff (PDF)

Subclinical thyroid disorders: significance and clinical impact

Journal of clinical pathology, 2010-05, Vol.63 (5), p.379-386

2010

Volltextzugriff (PDF)

Correction: Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus

PloS one, 2015-09, Vol.10 (9), p.e0138844-e0138844

2015

Volltextzugriff (PDF)

Age May Influence the Impact of TRAbs on Thyroid Function and Relapse-Risk in Patients With Graves Disease

The journal of clinical endocrinology and metabolism, 2019-05, Vol.104 (5), p.1378-1385

2019

Volltextzugriff (PDF)

The prevalence and significance of nonuniform thyroid radio‐isotope uptake in patients with Graves’ disease

Clinical endocrinology (Oxford), 2022-07, Vol.97 (1), p.100-105

2022

Volltextzugriff (PDF)

Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study

Cardiovascular diabetology, 2016-08, Vol.15 (1), p.116-116, Article 116

2016

Volltextzugriff (PDF)

Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement Therapy

The journal of clinical endocrinology and metabolism, 2010-01, Vol.95 (1), p.319-322

2010

Volltextzugriff (PDF)

The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds

Thyroid (New York, N.Y.), 2016-06, Vol.26 (6), p.765

2016

Volltextzugriff (PDF)

Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction

Cardiovascular diabetology, 2016-02, Vol.15 (1), p.27-27, Article 27

2016

Volltextzugriff (PDF)

Classical Endocrine Diseases Causing Obesity

Frontiers of hormone research, 2008-01, Vol.36, p.212-228

2008

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieObesity

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(45)
Buchkapitel
(3)

Sprache

Englisch
(48)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(38)
Humans
(31)
Endocrinology & Metabolism
(23)
Male
(18)
Adult
(17)
Female
(17)
Middle Aged
(16)
Biological And Medical Sciences
(11)
Cardiovascular Diseases
(10)
Diabetes
(10)
Endocrinopathies
(10)
Medical Sciences
(10)
Vascular Endothelial Growth Factor
(10)
Aged
(9)
Cardiovascular Disease
(9)
Fundamental And Applied Biological Sciences. Psychology
(9)
Vertebrates: Endocrinology
(9)
Biochemistry & Molecular Biology
(8)
Diabetes Mellitus
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Overexpression of miR-199b-5p in Colony Forming Unit-Hill’s Colonies Positively Mediates the Inflammatory Response in Subclinical Cardiovascular Disease Model: Metformin Therapy Attenuates Its Expression

MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus)

The Influence of Age on the Relationship between Subclinical Hypothyroidism and Ischemic Heart Disease: A Metaanalysis

Decoding of miR-7-5p in Colony Forming Unit-Hill Colonies as a Biomarker of Subclinical Cardiovascular Disease-A MERIT Study

The Role of miR-342 in Vascular Health. Study in Subclinical Cardiovascular Disease in Mononuclear Cells, Plasma, Inflammatory Cytokines and PANX2

Proangiogenic Effect of Metformin in Endothelial Cells Is via Upregulation of VEGFR1/2 and Their Signaling under Hyperglycemia-Hypoxia

Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1/2 and other parameters of vascular health

Subclinical Thyrotoxicosis and Cardiovascular Risk: Assessment of Circulating Endothelial Progenitor Cells, Proangiogenic Cells, and Endothelial Function

Deciphering the Role of miR-200c-3p in Type 1 Diabetes (Subclinical Cardiovascular Disease) and Its Correlation with Inflammation and Vascular Health

Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study

Upregulation of Anti-Angiogenic miR-106b-3p Correlates Negatively with IGF-1 and Vascular Health Parameters in a Model of Subclinical Cardiovascular Disease: Study with Metformin Therapy

Upregulated miR-18a-5p in Colony Forming Unit-Hill’s in Subclinical Cardiovascular Disease and Metformin Therapy; MERIT Study

Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up

Levothyroxine Improves Abnormal Cardiac Bioenergetics in Subclinical Hypothyroidism: A Cardiac Magnetic Resonance Spectroscopic Study

The Beneficial Effect of l-Thyroxine on Cardiovascular Risk Factors, Endothelial Function, and Quality of Life in Subclinical Hypothyroidism: Randomized, Crossover Trial

Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus

Subclinical thyroid disorders: significance and clinical impact

Correction: Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus

Age May Influence the Impact of TRAbs on Thyroid Function and Relapse-Risk in Patients With Graves Disease

The prevalence and significance of nonuniform thyroid radio‐isotope uptake in patients with Graves’ disease

Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study

Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement Therapy

The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds

Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction

Classical Endocrine Diseases Causing Obesity

Aktive Filter

Suchergebnisse filtern